PUBLISHER: The Business Research Company | PRODUCT CODE: 1764253
PUBLISHER: The Business Research Company | PRODUCT CODE: 1764253
At-home genetic testing, also known as direct-to-consumer (DTC) genetic testing, involves kits that enable individuals to collect their DNA samples-typically through saliva or a cheek swab-from the convenience of their home. These tests are designed to analyze genetic data to provide insights into ancestry, health risks, physical traits, or carrier status for inherited conditions, supporting more personalized health and lifestyle decisions.
The primary types of at-home genetic tests include ancestry testing, health and wellness testing, disease risk assessment, carrier testing, and others. Ancestry testing analyzes an individual's DNA to identify ancestral origins and ethnic background. The technologies commonly used in these tests include next-generation sequencing, polymerase chain reaction (PCR), microarray, and more. Sample types often include saliva, blood, cheek swabs, urine, and other biological materials. Applications of at-home genetic testing span personal use, clinical use, research, pharmaceutical development, and nutrition, with products distributed through online platforms, retail pharmacies, and additional channels.
The at-home genetic testing market research report is one of a series of new reports from The Business Research Company that provides at-home genetic testing market statistics, including at-home genetic testing industry global market size, regional shares, competitors with a at-home genetic testing market share, detailed at-home genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the at-home genetic testing industry. This at-home genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The at-home genetic testing market size has grown rapidly in recent years. It will grow from $3.47 billion in 2024 to $4.02 billion in 2025 at a compound annual growth rate (CAGR) of 15.9%. The growth during the historic period can be attributed to the increasing demand for pharmacogenomics, the growing number of companies in the space, the expansion of mobile applications, rising consumer preference for privacy, and increased investment in consumer genetic startups.
The at-home genetic testing market size is expected to see rapid growth in the next few years. It will grow to $7.18 billion in 2029 at a compound annual growth rate (CAGR) of 15.6%. The growth projected for the forecast period can be attributed to the increasing prevalence of chronic diseases, heightened awareness of genetic testing, a rise in genetic disorders, growing healthcare expenditures, and a surge in consumer demand for personalized health insights. Key trends expected during this period include technological innovations, the integration of artificial intelligence, advancements in data analytics, the expansion of telemedicine, and the emergence of pharmacogenomics.
The increasing adoption of telehealth is expected to drive the growth of the at-home genetic testing market in the coming years. Telehealth refers to the use of digital technologies-such as computers, smartphones, and video conferencing-to deliver and manage healthcare services remotely. Its rising adoption is attributed to the convenience it offers and its ability to expand access to healthcare, particularly for individuals in remote, rural, or underserved regions. At-home genetic testing complements telehealth by supplying personalized genetic data that healthcare providers can utilize during virtual consultations. This information enables physicians to tailor treatment strategies, manage chronic illnesses, and deliver precise health recommendations from a distance. For example, in February 2023, a survey conducted by Rock Health-a U.S.-based company focused on digital health innovation-with 8,014 participants from July to August 2022 found that 80% of respondents had used telemedicine at least once, representing an 8% increase from 72% in 2021. Thus, the growing adoption of telehealth is contributing to the expansion of the at-home genetic testing market.
Leading companies in the at-home genetic testing market are prioritizing the development of innovative solutions, such as at-home DNA collection kits, to improve the accuracy of sample collection. These user-friendly kits allow individuals to collect DNA samples-typically through saliva or cheek swabs-without the need for a clinical visit. For example, in February 2022, DNALABS, a biotechnology company based in Canada, introduced at-home genetic testing solutions that enable users to gather DNA samples using a simple cheek swab kit. These kits are designed to offer personalized insights related to health, wellness, and medication response based on an individual's genetic profile. Each kit generally includes a cheek swab, collection vial, step-by-step instructions, a consent form, and a prepaid return envelope. After the sample is submitted to a certified laboratory, users receive comprehensive reports to support informed decisions about their health, nutrition, fitness, and treatment options.
In February 2025, Tempus AI Inc., a health technology company based in the United States, acquired Ambry Genetics Corporation for an undisclosed amount. Through this acquisition, Tempus seeks to bolster its precision medicine capabilities by incorporating Ambry Genetics' proficiency in genetic testing to advance AI-powered diagnostics and improve patient care. Ambry Genetics is a U.S.-based biotechnology firm specializing in clinical-grade genetic testing.
Major players in the at-home genetic testing market are Labcorp Holdings Inc., AncestryDNA, Myriad Genetics Inc., 23andMe Inc., LetsGetChecked, Helix OpCo LLC, Everlywell Inc., Genos Inc., Vitagene Inc., Orig3n Inc., Mapmygenome India Limited, CircleDNA, Alpha Biolaboratories Limited, EasyDNA Limited, African Ancestry Inc., Futura Genetics Ltd., Living DNA Ltd., Nebula Genomics Inc., TellmeGen S.L., Xcode Life Sciences Pvt. Ltd., Color Health Inc.
North America was the largest region in the at-home genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in at-home genetic testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the at-home genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The at-home genetic testing market consists of revenues earned by entities by providing services such as skin and aging DNA analysis, exome sequencing, and relationship testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The at-home genetic testing market also includes sales of whole genome sequencing kits, saliva collection kits, and hair sample kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
At-Home Genetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on at-home genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for at-home genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The at-home genetic testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.